ACT BORTEZOMIB

Google image searchProduct monograph

Active ingredient

bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL

DIN: 02438399

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 30-DEC-2020

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XG — Proteasome inhibitors (ATC, ATC/DDD)
• L01XG01 — BORTEZOMIB (ATC/DDD)

Reference brand drug: Velcade

External Links for Act Bortezomib

Search on Google

• Act Bortezomib side effects
• Act Bortezomib dosage
• bortezomib side effects
• bortezomib dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find act bortezomib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.